Rhythm Pharmaceuticals Inc (NASDAQ:RYTM)
| 21.57 Delayed Data As of Oct 03 |  -0.53 / -2.40%Today’s Change | 15.50 Today|||52-Week Range 34.99 | -25.93% Year-to-Date |
Five Year Financial Summary
| All Currency in US Dollars | 4 Year Trend | |||||
|---|---|---|---|---|---|---|
2015 | 2016 | 2017 | 2018 | |||
| Revenue and Income | Net Revenues | 0.00 | 0.00 | 0.00 | 0.00 | -- |
| Depreciation And Amortization | -- | 144.0K | 223.0K | 442.0K | ||
| Operating Expenses | Gross Income | 0.00 | -144.0K | -223.0K | -442.0K | |
| General Expenses | 10.6M | 25.8M | 32.2M | 78.0M | ||
| Research And Development | 7.1M | 19.6M | 22.9M | 50.3M | ||
| Total Operating Expenses | 10.6M | 25.9M | 32.4M | 78.4M | ||
| Non-Operating Expenses | Operating Income | -10.6M | -25.9M | -32.4M | -78.4M | |
| Extraordinary Charge | -500.0K | 0.00 | -1.9M | 0.00 | ||
| Income Taxes, Minority Interest and Extra Items | Pre-Tax Income | -11.1M | -25.9M | -33.7M | -74.1M | |
| Net Income | -12.0M | -29.1M | -37.6M | -74.1M | ||
| Shares To Calculate EPS | Shares To Calculate EPS | 27.1M | 27.1M | 13.3M | 31.0M | |
| Shares To Calculate EPS Diluted | 27.1M | 27.1M | 13.3M | 31.0M | ||
| Earnings Per Share | EPS | -$0.44 | -$1.07 | -$2.83 | -$2.39 | |
| EPS Diluted | -$0.44 | -$1.07 | -$2.83 | -$2.39 | ||
